Marijuana Stocks Weekly – Hot Stock Watch List
ATTBF, TRTC, GWPH, TWMJF, MDCN, CANN, PHOT,
VPOR (formerly SPLI), MCIG, FITX, CANA
GW Pharmaceuticals – GWPH
On Jim Cramer’s Mad Money Friday, he devoted an entire segment of the show to share a very positive if not glowing perspective on the company’s future. Morgan Stanley analysts also last week shared a bullish price target of $103. Another factor for investors to consider is that GWPH is a lucrative option for institutional buyers boxed out of investing in most other marijuana-related companies as they are penny stocks. GW Pharma certainly shows promise as an investment and the company’s stock trades on the NASDAQ, not the OTC.
Seeking new high, Cramer turns to cannabis
Terra Tech – TRTC
Terra Tech’s plans and marijuana-based initiatives in Las Vegas Nevada were highlighted this week in an article at The Verge online. CEO Derek Peterson reveals in the article that he believes the Las Vegas marijuana market could be anywhere from $600 million to $1.5 billion, representing a massive opportunity for the company. Terra Tech has applied for cultivation and dispensary licenses in Nevada and investors remain hopeful that these licenses will come to fruition helping to firmly establish Terra Tech as a major player in this highly lucrative market.
High rollers: Las Vegas is poised to become the Disneyland of weed
Abattis Bioceuticals – ATTBF
Abattis revealed a new addition to its vertically integrated business model in its acquisition of a 34% interest in Instant Payment Systems LLC, a Washington state entity focused on payment processing for medical marijuana dispensaries.
Mike Withrow, CEO of Abattis stated “This transaction enables the company to provide a valuable service and solves a problem to an unmet need for dispensaries of medical marijuana and other botanical medicines. The IPS cards and phone apps can be branded and loyalty programs can be used so the patients save money and can maintain a budget while managing their purchases of Medical Marijuana. The system also protects dispensaries from carrying cash as funds are automatically credited to their accounts. It is becoming clear that investors understand our comprehensive business model. We are not just about cultivation. We look forward to integrating this technology into our Washington State Lab model. We believe the use of this system by dispensaries will become the minimum standard requirement for dispensaries worldwide. We wished to thank the investment community for its support through our recent period of growth.”
Abattis continues to be my strongest recommendation for investors looking for an MJ company establishing itself to reap the rewards of the changing legal landscape of marijuana both in Canada and the US. The company has shared with investors that it is in progress towards acquiring MMPR licensing and also seeking a Canadian controlled substances license, both which I believe will be very positive catalysts for ATTBF.
In full disclosure, ATTBF has become my largest MJ portfolio holding.
Abattis Announces the Acquisition of 34% Interest in Instant Payment Systems LLC
Abattis looks to be MMJ sector’s next banker – Stockhouse
Growlife – PHOT
The MJ investing community continues to wonder if PHOT will be able to conquer the challenge that was handed to them by the shocking SEC suspension last month. Despite the company’s assertion that the suspension was out of their control, the stock price has suffered greatly and now it seems only the bravest believers in PHOT’s potential to return to the OTC are buying and holding the company’s stock.
After a press release from the company stating that directors had cancelled their stock grants for Q1 and restructured director compensation, the pps rose to a new level of support closing the week at .19.
PHOT however continues to suffer the penalties of a difficult trading environment while it trades on the grey market. The grey market trading for PHOT will continue until a market maker files application to trade the company OTC. While the best hopes of investors is that that could happen within the month of May, there is not yet any evidence that this will be the case.
The company was featured this weekend on a video segment at The Street online where they explain the situation facing the company and reveal some exclusive interview details from Growlife CEO Sterling Scott who indicates he “believes the company will fully recover from the federally induced hiatus.”
MJ Stocks Still Suffer Increased Scrutiny and Dank Doubts – The Street
GrowLife Establishes Board Governance Policies, Restructures Compensation for Independent Directors
PHOT email inquiries: firstname.lastname@example.org
PHOT Investor Hotline 866-632-3111
Medican – MDCN
Medican is focused on becoming a commercially licensed producer of marijuana in Canada. The company’s stock, MDCN however, continues its downward trend of the last few weeks and now stands at levels not seen since February of this year. I think that the company has a great focus of facilitating large scale MJ production and real estate acquisition and partnership to that end, but investors are awaiting more information on the company’s financing prospects, and are currently in absence of information pertaining to progress on their MMPR license application progress.
In the links below, I have included author and investor Matt Finston’s bullish case for MDCN. I follow Matt’s writing closely and recommend you follow too as he is actively researching and making calls for MJ-related companies that he believes have the most potential to succeed over time. You can follow Matt’s writing on Seeking Alpha and on Twitter.
Retrofit of 400,000 Square Foot Cultivation Facility
Medican: where the future of healthcare is growing
SA Author Matt Finston’s article – Canadian Marijuana Stocks: Medican And IHMML Give Investors A Reason To Be Bullish – April 8